Derek Jones, Lucy Fellow and CEO, Babraham Bioscience Technologies, thanks staff for success of the campus
A recent report The Economic Impact of the Babraham Research Campus shows the centrality of Babraham in the wider context of Cambridge Life Sciences and highlights its great research outcomes. Commissioned by the Campus partners, Babraham Bioscience Technologies (BBT), the organisation which develops and manages the Babraham Research Campus, UKRI-BBSRC and the Babraham Institute, the report identifies the successful contribution the Campus makes to both the commercialisation of life science research and the life science knowledge base.
Derek Jones, Lucy Fellow and CEO, BBT commented:
“I am delighted to see that the findings from this report confirms our own internal data and anecdotal evidence of the impact of the Campus. We have tried to ensure that the support we offer to life science companies, whether it be the provision of flexible lease structures; access to science capabilities; or the nurturing and engaging community, is impactful in terms of jobs, scientific progress and increased economic activity, both locally and for the UK as a whole. It appears in many respects that we have succeeded. I would like to take this opportunity to thank all the BBT staff on Campus for the part they have played in making the Campus the success which from this evidence it is.”
The report confirms that strategic public sector funding for life sciences, such as that received by the Babraham Research Campus, delivers significant impact to the UK economy, healthcare and society. Over three quarters of companies surveyed considered their location on Campus as a very important or critically important factor in helping them to access laboratory and office space.
Read more, watch the campus video, download the executive summary or the whole report here Campus Impact Report.
Video here too:
About Derek Jones
Derek Jones is Chief Executive at Babraham Bioscience Technologies Ltd at the Babraham Research Campus. Derek’s wealth of experience includes over 25 years' in the life-science industry as both a scientist and in business development and corporate development, with first-hand experience of establishing biomedical ventures. Read more on the Fellow’s profile page